Ozempic, Wegovy and other new drugs are selected for Medicare’s price negotiations
By AMANDA SEITZ
WASHINGTON (AP) — Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden administration said Friday.
The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration and almost assures billions of dollars in savings for taxpayers.
Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey.
More Stories
Hinton calls for UK ban on superintelligent AI as MPs table bill
Geoffrey Hinton, the Nobel Prize winner known as the godfather of artificial intelligence, has called on the government to prohibit...
Warmest summer on record brings mixed fortunes for South West traders
The UK’s warmest summer on record has produced mixed results for businesses in south-west England and the Channel Islands, with...
Jaguar Land Rover to cut 4,000 jobs as minister rules out bailout
Jaguar Land Rover is to cut as many as 4,000 jobs over two years as it targets about £1.7bn of...
One in five family manufacturers weigh overseas sale over IHT changes
More than one in five family-owned manufacturers are considering a sale to overseas buyers in response to changes to inheritance...
Molten Ventures raises £175m growth fund for UK tech scale-ups
Molten Ventures, the London-listed venture capital firm that backed Revolut and Zopa, has raised £175m for a new fund aimed...
CBI tells Healey £345bn business costs are holding back investment
Rising costs are damaging business investment and undermining the government’s efforts to raise living standards, the CBI has warned the...